Research output per year
Research output per year
Search results
-
2022
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
Martin de la Fuente, L., Li, M., Måsbäck, A., Malander, S., Kannisto, P. & Hedenfalk, I., 2022.Research output: Contribution to conference › Poster
File52 Downloads (Pure) -
2021
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, L., Li, M., Veerla, S. & Hedenfalk, I., 2021 May 11, (Accepted/In press).Research output: Contribution to conference › Poster
-
2020
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, L., Westbom-Fremer, S., Arildsen, N. S., Hartman, L., Malander, S., Kannisto, P., Måsbäck, A. & Hedenfalk, I., 2020 Jul, In: Virchows Archiv: an international journal of pathology. 477, 1, p. 83-91 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
2017
Claudin-4 expression is associated with progression free survival in ovarian cancer, but not with chemotherapy response
Martin de la Fuente, L., Malander, S., Hartman, L., Jönsson, J.-M., Ebbesson, A., Nilbert, M., Måsbäck, A. & Hedenfalk, I., 2017, In: International Journal of Gynecological Pathology. 37, 2, p. 101-109Research output: Contribution to journal › Article › peer-review
Open Access